A prospective cohort study in PLWH on antiretrovirals, receiving primary vaccination with BNT162b2 and boosting dose with a first-generation m-RNA vaccine - ORCHESTRA program
Latest Information Update: 23 Jan 2025
Price :
$35 *
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics; Therapeutic Use
- 23 Jan 2025 New trial record